| Trial ID: | L0449 |
| Source ID: | IRCT20191124045488N1
|
| Associated Drug: |
Celery seed
|
| Title: |
Survey the Effect of celery seed on serum levels of hepatic enzymes, lipid profile, glycemic parameters and hepatic steatosis degree in nonalcoholic fatty liver disease patients, with overweight and obesity
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-alcoholic fatty liver disease. <br>Fatty (change of) liver, not elsewhere classified;K76.0
|
| Interventions: |
Intervention 1: Intervention group: getting 4 capsule of celery seed (500mg) per day fo 6 weeks. Intervention 2: Control group: getting 4 capsules of plasebo for 6 weeks.
|
| Outcome Measures: |
Hepatic enzymes (AST, ALT). Timepoint: Before and after intervention. Method of measurement: Use of enzymatic kits.;Lipid profile (Triglyceride, total cholesterole, LDL, VLDL, HDL). Timepoint: Before and after intervention. Method of measurement: Use of enzymatic kits.;Insulin levels. Timepoint: Before and after intervention. Method of measurement: Use of enzymatic kits.;Liver Echogenicity. Timepoint: Before and after intervention. Method of measurement: Using an ultrasound machine by a radiologist.;The total amount of calorie received. Timepoint: Before and after intervention. Method of measurement: Using a 24-hour food recording questionnaire.;Hs-CRP. Timepoint: Before and after intervention. Method of measurement: Use of enzymatic kits.;Body fat percentage. Timepoint: Before and after intervention. Method of measurement: Using body composition measuring device.;Weight. Timepoint: Before and after intervention. Method of measurement: Using digital scales.;Waist and hip circumference. Timepoint: Before and after intervention. Method of measurement: Use non-elastic tape meters.;Fasting Blood sugar. Timepoint: Before and after intervention. Method of measurement: Use of enzymatic kits.;HOMA-IR. Timepoint: Before and after intervention. Method of measurement: HOMA-IR=BS(mmol/lit)??insulin(microunit/lit)/22.5.nan
|
| Sponsor/Collaborators: |
Ahvaz University of Medical Sciences
|
| Gender: |
All
|
| Age: |
18 years65 years
|
| Phases: |
Phase 2
|
| Enrollment: |
44
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: 44 subjects were divided into two groups of 22 intervention and control groups based on the block design method. In th
|
| Start Date: |
29/11/2019
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
17 December 2019
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/43736
|
